Targeting C5a/C5aR1 signaling ameliorates COVID-19 immunopathology

By | July 6, 2022
A new study investigated the role of complement component 5a (C5a) and its receptor (C5a receptor type 1, C5aR1) in the pathophysiology of COVID-19.